| Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and … C Chung, M Christianson Journal of oncology pharmacy practice 20 (1), 11-28, 2014 | 79 | 2014 |
| Development and implementation of an interdisciplinary oncology program in a community hospital C Chung, A Collins, N Cui American Journal of Health-System Pharmacy 68 (18), 1740-1747, 2011 | 46 | 2011 |
| Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway C Chung The Bulletin of the American Society of Hospital Pharmacists 75 (13), 945-952, 2018 | 43 | 2018 |
| Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system C Chung, S Patel, R Lee, L Fu, S Reilly, T Ho, J Lionetti, MD George, ... The Bulletin of the American Society of Hospital Pharmacists 75 (6), 398-406, 2018 | 43 | 2018 |
| Role of immunotherapy in targeting the bone marrow microenvironment in multiple myeloma: an evolving therapeutic strategy C Chung Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (1 …, 2017 | 36 | 2017 |
| Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics C Chung Journal of Oncology Pharmacy Practice 22 (3), 461-476, 2016 | 36 | 2016 |
| Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer C Chung, N Pherwani American journal of health-system pharmacy 70 (21), 1887-1896, 2013 | 34 | 2013 |
| Current targeted therapies in lymphomas C Chung American Journal of Health-System Pharmacy 76 (22), 1825-1834, 2019 | 26 | 2019 |
| Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer C Chung, MSH Lam American journal of health-system pharmacy 70 (18), 1579-1587, 2013 | 23 | 2013 |
| Trametinib: a novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma C Chung, S Reilly American Journal of Health-System Pharmacy 72 (2), 101-110, 2015 | 22 | 2015 |
| Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemia C Chung, R Lee Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (12 …, 2014 | 20 | 2014 |
| Driving toward precision medicine for acute leukemias: are we there yet? C Chung, H Ma Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 18 | 2017 |
| From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer C Chung American Journal of Health-System Pharmacy 77 (24), 2064-2073, 2020 | 17 | 2020 |
| Management of neuroendocrine tumors C Chung American Journal of Health-System Pharmacy 73 (21), 1729-1744, 2016 | 16 | 2016 |
| Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation C Chung J Oncol Pharm Practice, https://doi.org/10.1177/1078155221100552, 2021 | 15 | 2021 |
| To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade C Chung Journal of Oncology Pharmacy Practice 25 (3), 663-673, 2019 | 13 | 2019 |
| An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly (adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis C Chung, R Lee Journal of Oncology Pharmacy Practice 23 (6), 454-469, 2017 | 13 | 2017 |
| Omacetaxine for treatment-resistant or treatment-intolerant adult chronic myeloid leukemia C Chung American journal of health-system pharmacy 71 (4), 279-288, 2014 | 12 | 2014 |
| Targeting the androgen receptor signaling pathway in advanced prostate cancer C Chung, K Abboud American Journal of Health-System Pharmacy 79 (15), 1224-1235, 2022 | 8 | 2022 |
| New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab C Chung Annals of Pharmacotherapy, 2020 | 7 | 2020 |
